Fanny Petit

2.2k total citations
32 papers, 1.3k citations indexed

About

Fanny Petit is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Fanny Petit has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cellular and Molecular Neuroscience, 13 papers in Molecular Biology and 13 papers in Physiology. Recurrent topics in Fanny Petit's work include Alzheimer's disease research and treatments (13 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers) and Genetic Neurodegenerative Diseases (8 papers). Fanny Petit is often cited by papers focused on Alzheimer's disease research and treatments (13 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers) and Genetic Neurodegenerative Diseases (8 papers). Fanny Petit collaborates with scholars based in France, United States and Switzerland. Fanny Petit's co-authors include Philippe Hantraye, Martine Guillermier, Gilles Bonvento, Diane Houitte, Marc Dhénain, Lucile Ben Haim, Carole Escartin, Emmanuel Brouillet, Nicole Déglon and Thierry Delzescaux and has published in prestigious journals such as Journal of Neuroscience, Physical review. B, Condensed matter and PLoS ONE.

In The Last Decade

Fanny Petit

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fanny Petit France 18 496 444 430 395 173 32 1.3k
Martine Guillermier France 18 667 1.3× 463 1.0× 636 1.5× 315 0.8× 251 1.5× 35 1.6k
Karoly Nikolich United States 18 966 1.9× 367 0.8× 484 1.1× 434 1.1× 153 0.9× 21 1.9k
Anne‐Sophie Hérard France 16 380 0.8× 283 0.6× 318 0.7× 307 0.8× 157 0.9× 47 1.1k
Christian Madry Germany 16 552 1.1× 714 1.6× 532 1.2× 349 0.9× 107 0.6× 27 1.5k
Carol A. Miller United States 17 752 1.5× 616 1.4× 486 1.1× 950 2.4× 167 1.0× 28 1.9k
Elizabeth Bien United States 5 662 1.3× 344 0.8× 327 0.8× 390 1.0× 230 1.3× 7 1.4k
Eryn L. Werry Australia 16 354 0.7× 310 0.7× 293 0.7× 228 0.6× 171 1.0× 44 1.1k
Jeremy H. Herskowitz United States 20 563 1.1× 198 0.4× 451 1.0× 628 1.6× 186 1.1× 37 1.4k
Claudia Prada United States 10 537 1.1× 577 1.3× 375 0.9× 1.2k 3.0× 153 0.9× 10 1.7k
Andrew F. Teich United States 22 642 1.3× 266 0.6× 481 1.1× 603 1.5× 220 1.3× 42 1.8k

Countries citing papers authored by Fanny Petit

Since Specialization
Citations

This map shows the geographic impact of Fanny Petit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny Petit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny Petit more than expected).

Fields of papers citing papers by Fanny Petit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanny Petit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny Petit. The network helps show where Fanny Petit may publish in the future.

Co-authorship network of co-authors of Fanny Petit

This figure shows the co-authorship network connecting the top 25 collaborators of Fanny Petit. A scholar is included among the top collaborators of Fanny Petit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanny Petit. Fanny Petit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacquier‐Sarlin, Muriel R., Eve Borel, Fanny Petit, et al.. (2024). Transmissible long-term neuroprotective and pro-cognitive effects of 1–42 beta-amyloid with A2T icelandic mutation in an Alzheimer’s disease mouse model. Molecular Psychiatry. 29(12). 3707–3721. 3 indexed citations
2.
Jacquier‐Sarlin, Muriel R., Eve Borel, Fanny Petit, et al.. (2023). Long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with Osaka mutation. Acta Neuropathologica Communications. 11(1). 66–66. 3 indexed citations
3.
Hérard, Anne‐Sophie, Fanny Petit, Martine Guillermier, et al.. (2020). Induction of amyloid-β deposits from serially transmitted, histologically silent, Aβ seeds issued from human brains. Acta Neuropathologica Communications. 8(1). 205–205. 8 indexed citations
4.
Ceyzériat, Kelly, Karine Cambon, Fanny Petit, et al.. (2020). Complex roles for reactive astrocytes in the triple transgenic mouse model of Alzheimer disease. Neurobiology of Aging. 90. 135–146. 24 indexed citations
5.
Lam, Suzanne, Anne‐Sophie Hérard, James E. Koch, et al.. (2019). Encephalopathy induced by Alzheimer brain inoculation in a non-human primate. Acta Neuropathologica Communications. 7(1). 126–126. 34 indexed citations
6.
Valenzuela, Anthony E., et al.. (2018). In VivoMRI of Functionalized Iron Oxide Nanoparticles for Brain Inflammation. Contrast Media & Molecular Imaging. 2018. 1–10. 22 indexed citations
7.
Vandesquille, Matthias, Clément M. Garin, Sandro Alves, et al.. (2017). Contrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer’s disease brains. Scientific Reports. 7(1). 4955–4955. 28 indexed citations
8.
Haim, Lucile Ben, Kelly Ceyzériat, María-Angeles Carrillo-de Sauvage, et al.. (2015). The JAK/STAT3 Pathway Is a Common Inducer of Astrocyte Reactivity in Alzheimer's and Huntington's Diseases. Journal of Neuroscience. 35(6). 2817–2829. 232 indexed citations
9.
Gubellini, Paolo, Nicolas Mérienne, Fanny Petit, et al.. (2015). Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease. Neurobiology of Disease. 86. 131–139. 22 indexed citations
10.
Francelle, Laetitia, Laurie Galvan, Marie‐Claude Gaillard, et al.. (2014). Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease. Human Molecular Genetics. 24(6). 1563–1573. 22 indexed citations
11.
Lavisse, Sonia, Kayo Inoue, Marie‐Anne Peyronneau, et al.. (2014). [18F]DPA-714 PET imaging of translocator protein TSPO (18 kDa) in the normal and excitotoxically-lesioned nonhuman primate brain. European Journal of Nuclear Medicine and Molecular Imaging. 42(3). 478–494. 42 indexed citations
12.
Damiano, Maria, Elsa Diguet, Carole Malgorn, et al.. (2013). A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Human Molecular Genetics. 22(19). 3869–3882. 89 indexed citations
13.
Lavisse, Sonia, Martine Guillermier, Anne‐Sophie Hérard, et al.. (2012). Reactive Astrocytes Overexpress TSPO and Are Detected by TSPO Positron Emission Tomography Imaging. Journal of Neuroscience. 32(32). 10809–10818. 276 indexed citations
14.
Galvan, Laurie, Marie‐Claude Gaillard, Carole Malgorn, et al.. (2012). Capucin does not modify the toxicity of a mutant Huntingtin fragment in vivo. Neurobiology of Aging. 33(8). 1845.e5–1845.e6. 6 indexed citations
15.
Martin, Claire, Diane Houitte, Martine Guillermier, et al.. (2012). Alteration of sensory-evoked metabolic and oscillatory activities in the olfactory bulb of GLAST-deficient mice. Frontiers in Neural Circuits. 6. 1–1. 90 indexed citations
16.
Santin, Mathieu, Olène Dorieux, Nelly Joseph‐Mathurin, et al.. (2012). In Vivo Cross-sectional Characterization of Cerebral Alterations Induced by Intracerebroventricular Administration of Streptozotocin. PLoS ONE. 7(9). e46196–e46196. 79 indexed citations
17.
Dufour, Noëlle, Fanny Petit, Martine Guillermier, et al.. (2012). Restricted Transgene Expression in the Brain with Cell-Type Specific Neuronal Promoters. Human Gene Therapy Methods. 23(4). 242–254. 29 indexed citations
18.
Dufour, Noëlle, Fanny Petit, Martine Guillermier, et al.. (2012). Restricted transgene expression in the brain with cell-type specific neuronal promoters. Human Gene Therapy Methods. 2064670904–2064670904. 2 indexed citations
19.
Petiet, Alexandra, Mathieu Santin, Anne Bertrand, et al.. (2011). Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice. Neurobiology of Aging. 33(8). 1533–1544. 40 indexed citations
20.
Dorieux, Olène, Jean‐Luc Picq, Fanny Petit, et al.. (2009). Age-associated cerebral atrophy in mouse lemur primates. Neurobiology of Aging. 32(5). 894–906. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026